SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 8.69% in the revenue at Rs. 14371.40 millions was reported in the December 2023 quarter as compared to Rs. 13221.90 millions during year-ago period.A good growth in profit of 25.99% reported to Rs. 3109.80  millions over Rs. 2468.30 millions of corresponding previous quarter.The company reported a good operating profit of 4433.00 millions compared to 3564.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 14371.40 13221.90 8.69 44102.80 40056.40 10.10 53487.30 49133.20 8.86
Other Income 556.10 442.30 25.73 1671.20 1045.20 59.89 1541.50 831.60 85.37
PBIDT 4433.00 3564.30 24.37 12906.90 10300.20 25.31 13597.80 11649.30 16.73
Interest 31.70 37.90 -16.36 96.40 119.80 -19.53 159.90 191.00 -16.28
PBDT 4401.30 3526.40 24.81 12810.50 10180.40 25.83 13437.90 11458.30 17.28
Depreciation 179.70 178.10 0.90 529.80 526.30 0.67 699.70 661.00 5.85
PBT 4221.60 3348.30 26.08 12280.70 9654.10 27.21 12738.20 10797.30 17.98
TAX 1111.80 880.00 26.34 3139.10 2474.20 26.87 3244.10 2810.30 15.44
Deferred Tax -21.60 -16.80 28.57 -57.20 -47.30 20.93 -11.90 -1.30 815.38
PAT 3109.80 2468.30 25.99 9141.60 7179.90 27.32 9494.10 7987.00 18.87
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 30.85 26.96 14.42 29.27 25.71 13.81 25.42 23.71 7.22

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×